Akin C - Search Results

1

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD. Valent P, et al. Among authors: akin c. Cancer Res. 2017 Mar 15;77(6):1261-1270. doi: 10.1158/0008-5472.CAN-16-2234. Epub 2017 Mar 2. Cancer Res. 2017. PMID: 28254862 Free PMC article. Review.

2

Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.

Worobec AS, Akin C, Scott LM, Metcalfe DD. Worobec AS, et al. Among authors: akin c. J Allergy Clin Immunol. 1998 Sep;102(3):523-4. doi: 10.1016/s0091-6749(98)70144-7. J Allergy Clin Immunol. 1998. PMID: 9768597 No abstract available.

3

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.

Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Metcalfe DD. Akin C, et al. Exp Hematol. 2000 Feb;28(2):140-7. doi: 10.1016/s0301-472x(99)00145-9. Exp Hematol. 2000. PMID: 10706069 Free article.

4

Mastocytosis complicating pregnancy.

Worobec AS, Akin C, Scott LM, Metcalfe DD. Worobec AS, et al. Among authors: akin c. Obstet Gynecol. 2000 Mar;95(3):391-5. doi: 10.1016/s0029-7844(99)00591-8. Obstet Gynecol. 2000. PMID: 10711550

5

Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.

Akin C, Schwartz LB, Kitoh T, Obayashi H, Worobec AS, Scott LM, Metcalfe DD. Akin C, et al. Blood. 2000 Aug 15;96(4):1267-73. Blood. 2000. PMID: 10942367 Free article. Clinical Trial.

6

Mastocytosis: molecular mechanisms and clinical disease heterogeneity.

Metcalfe DD, Akin C. Metcalfe DD, et al. Among authors: akin c. Leuk Res. 2001 Jul;25(7):577-82. doi: 10.1016/s0145-2126(01)00046-7. Leuk Res. 2001. PMID: 11377683 Review.

7

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Valent P, et al. Among authors: akin c. Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8. Leuk Res. 2001. PMID: 11377686 Review.

8

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?

Akin C, Scott LM, Metcalfe DD. Akin C, et al. Leuk Res. 2001 Jul;25(7):635-8. doi: 10.1016/s0145-2126(01)00023-6. Leuk Res. 2001. PMID: 11377688

9

Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL.

Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD. Mekori YA, et al. Among authors: akin c. J Clin Immunol. 2001 May;21(3):171-4. doi: 10.1023/a:1011083031272. J Clin Immunol. 2001. PMID: 11403223

10

Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin.

Daley T, Metcalfe DD, Akin C. Daley T, et al. Among authors: akin c. Blood. 2001 Aug 1;98(3):880-2. doi: 10.1182/blood.v98.3.880. Blood. 2001. PMID: 11468192 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters